SCOPE FLUIDICS SA ZY-10 Net Assets
SCOPE FLUIDICS SA ZY-10 net assets. Based on the latest financial reports, SCOPE FLUIDICS SA ZY-10 (S84) has net assets worth €162.43 Million EUR (≈ $189.90 Million USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€195.94 Million ≈ $229.07 Million USD) and total liabilities (€33.50 Million ≈ $39.17 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore S84 year-over-year net asset growth to track the company's year-over-year net asset growth rate.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €162.43 Million |
| % of Total Assets | 82.9% |
| Annual Growth Rate | 121.58% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 2094.93 |
Net Assets of SCOPE FLUIDICS SA ZY-10 (2021–2025)
Net assets of SCOPE FLUIDICS SA ZY-10 from 2021 to 2025. This chart illustrates how SCOPE FLUIDICS SA ZY-10's net assets have evolved over time, based on quarterly financial data. See S84 equity to assets ratio to measure how much of total assets are equity-financed.
Annual Net Assets for SCOPE FLUIDICS SA ZY-10 (2021–2025)
The table below shows the annual net assets of SCOPE FLUIDICS SA ZY-10 from 2021 to 2025. For live market cap and overall valuation, see market value of SCOPE FLUIDICS SA ZY-10.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | €162.43 Million ≈ $189.90 Million |
+10.99% |
| 2024-12-31 | €146.35 Million ≈ $171.10 Million |
+80.84% |
| 2023-12-31 | €80.93 Million ≈ $94.62 Million |
-75.69% |
| 2022-12-31 | €332.97 Million ≈ $389.28 Million |
+4841.72% |
| 2021-12-31 | €6.74 Million ≈ $7.88 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to SCOPE FLUIDICS SA ZY-10's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 6179200000.0% over the analyzed period, indicating profitable operations and earnings retention.
SCOPE FLUIDICS SA ZY-10 Net Assets Breakdown (December 2025)
SCOPE FLUIDICS SA ZY-10 net assets breakdown by equity component as of December 2025.
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | €4.53 Million | 2.79% |
| Other Components | €157.90 Million | 97.21% |
| Total Equity | €162.43 Million | 100.00% |
SCOPE FLUIDICS SA ZY-10 Competitors by Market Cap
The table below lists competitors of SCOPE FLUIDICS SA ZY-10 ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
China New Higher Education Group Limited
F:8CN
|
$94.52 Million |
|
ANDRADA MINING LTD.
F:9IA
|
$94.55 Million |
|
Kandi Technologies Group Inc
NASDAQ:KNDI
|
$94.58 Million |
|
Oil Terminal C
RO:OIL
|
$94.63 Million |
|
Peel Mining Ltd
AU:PEX
|
$94.48 Million |
|
Nasmedia Co. Ltd
KQ:089600
|
$94.47 Million |
|
Actinogen Medical Ltd
AU:ACW
|
$94.46 Million |
|
Themis Medicare Limited
NSE:THEMISMED
|
$94.45 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in SCOPE FLUIDICS SA ZY-10's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 146,351,000 to 162,431,000, a change of 16,080,000 (11.0%).
- Net loss of 46,364,000 reduced equity.
- New share issuances of 62,273,000 increased equity.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €-46.36 Million | -28.54% |
| Share Issuances | €62.27 Million | +38.34% |
| Other Changes | €171.00K | +0.11% |
| Total Change | €- | 10.99% |
Book Value vs Market Value Analysis
This analysis compares SCOPE FLUIDICS SA ZY-10's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.54x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has decreased from 11.08x to 0.54x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2021-12-31 | €2.51 | €27.80 | x |
| 2022-12-31 | €122.15 | €27.80 | x |
| 2023-12-31 | €29.69 | €27.80 | x |
| 2024-12-31 | €53.69 | €27.80 | x |
| 2025-12-31 | €51.27 | €27.80 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently SCOPE FLUIDICS SA ZY-10 utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -28.54%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -46364.00%
- • Asset Turnover: 0.00x
- • Equity Multiplier: 1.21x
- Recent ROE (-28.54%) is above the historical average (-31.66%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2021 | -246.88% | 0.00% | 0.00x | 7.83x | €-17.31 Million |
| 2022 | 95.65% | 78833.91% | 0.00x | 1.04x | €285.19 Million |
| 2023 | -23.21% | -3640.50% | 0.01x | 1.25x | €-26.88 Million |
| 2024 | 44.70% | 49939.69% | 0.00x | 1.18x | €50.79 Million |
| 2025 | -28.54% | -46364.00% | 0.00x | 1.21x | €-62.61 Million |
Industry Comparison
This section compares SCOPE FLUIDICS SA ZY-10's net assets metrics with peer companies in the Diagnostics & Research industry.
Industry Context
- Industry: Diagnostics & Research
- Average net assets among peers: $4,233,351,105
- Average return on equity (ROE) among peers: -14.74%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| SCOPE FLUIDICS SA ZY-10 (S84) | €162.43 Million | -246.88% | 0.21x | $94.51 Million |
| IZOTROPIC CORP. (1R3) | $-5.63 Million | 0.00% | 0.00x | $6.44 Million |
| ALPHAHELIX MOL.DIAGN. SK1 (4MB) | $10.41 Million | -90.99% | 0.83x | $839.64K |
| HANGZHOU TIGERMED CO. H 1 (5HZ1) | $24.06 Billion | 1.68% | 0.19x | $610.33 Million |
| Check-Cap Ltd (7CC) | $-1.45 Million | 0.00% | 0.00x | $9.20 Million |
| INTERGRATED DIA.H DL 025 (8I8) | $3.50 Billion | 30.79% | 1.04x | $246.03 Million |
| GENETIC ANALYSIS NK -60 (8V8) | $72.09 Million | -40.23% | 0.16x | $2.36 Million |
| GENINCODE PLC LS -01 (9PL) | $13.72 Million | -30.19% | 0.11x | $5.28 Million |
| INOVIQ LTD. (EGQ0) | $19.99 Million | -32.79% | 0.09x | $12.59 Million |
| Eurofins Scientific SE (ESF0) | $5.14 Billion | 6.04% | 1.12x | $11.18 Billion |
| ICON Public Limited Company (IJF) | $9.52 Billion | 8.31% | 0.77x | $7.52 Billion |
About SCOPE FLUIDICS SA ZY-10
Scope Fluidics S.A., a biotechnology company, designs and develops projects based on microfluidic technologies in medical diagnostics and healthcare in Poland. The company offers BacterOMIC, an antibiotic susceptibility testing. Scope Fluidics S.A. was founded in 2010 and is based in Warsaw, Poland.